Last edition
News about
The Drugs Controller General (India) has classified 135 medical devices related to ophthalmology under the provisions of Medical Devices Rules, 2017. In another notice, it has also classified 51 medical devices pertaining to respiratory treatments under the provisions of Medical Devices Rules
NPPA caps trade margin of 42 anti-cancer medicines, MRP of 562 brands gets reduced up to 90%
The National Pharmaceutical Pricing Authority (NPPA) has put a cap on trade margin of 42 select non-scheduled anti-cancer medicines under the "Trade Margin Rationalization (TMR)"
MaxCyte, Inc., a leading provider of cell-engineering platform technologies, announced the signing of a clinical and commercial license with Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines.
DCGI classifies 51 medical devices related to respiratory health under rules
The Drugs Controller General (India) has classified 51 medical devices pertaining to respiratory treatments under the provisions of Medical Devices Rules, 2017, the rule formed to regulate them with respect to the import, manufacture, sale and distribution, and clinical investigation
Mylab Discovery Solutions, India's leading biotechnology company, has joined forces with the US-based Hemex Health, a medical diagnostic device company focused on creating life-changing global health products, to develop next-generation diagnostic solutions for the Point-of-Care (POC)testing of coronavirus and other diseases
Health Gorilla, Ambra Health ink partnership for seamless digital medical imaging
Ambra Health, maker of the leading cloud-based, medical image management suite, and Health Gorilla, the leading provider of healthcare APIs, announced a partnership to enable medical image viewing directly within Health Gorilla's platform
PUCHO, an AI tech start-up, has launched a breakthrough AI powered noise print anti-copy labels to eliminate counterfeit. The multi-lingual App powered by Cypheme, a global artificial intelligence and brand protection solution to protect drugs & medical device brands against the growing menace of counterfeits
IPC flags safety alerts against etoricoxib, torsemide and quetiapine & valproic acid interaction
The Indian Pharmacopoeia Commission (IPC) which is the National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) has flagged safety alerts against etoricoxib, torsemide and quetiapine & valproic acid interaction.
Kite inks research pact with Appia Bio to develop allogeneic cell therapies
Kite, a Gilead Company and Appia Bio, an early stage biotechnology company, announced a collaboration and license agreement to research and develop HSC-derived cell therapies directed toward hematological malignancies. Under the partnership, Kite and Appia Bio will develop chimeric antigen receptor
Accelerate Diagnostics announced that the new IVD configuration of its Accelerate PhenoTest BC kit has been CE marked and is ready for use in Europe
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy